Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–20 of 31 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
NCT04587687
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT06948786
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +12 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
- Conditions
- B-Cell Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +35 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT06712810
- Conditions
- Blastic Plasmacytoid Dendritic Cell Neoplasm, Blood Protein Disorders, Bone Marrow Diseases, +87 more
- Locations
-
- Mayo Clinic in Arizona Scottsdale, Arizona, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT04205409
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT01644799
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
- Locations
-
- MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
- University of Chicago Chicago, Illinois, United States
- Washington University School of Medicine St Louis, Missouri, United States
- Weill Medical College of Cornell University New York, United States
NCT03035331
- Conditions
- Aggressive Non-Hodgkin Lymphoma, Chronic Disease, Disease Attributes, +31 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Completed
Lenalidomide and Obinutuzumab in Treating Patients With Relapsed Indolent Non-Hodgkin Lymphoma
NCT01995669
- Conditions
- Chronic Disease, Disease Attributes, Grade 3a Follicular Lymphoma, +28 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT04578600
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +39 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
NCT02927964
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +17 more
- Locations
-
- Stanford University, School of Medicine Palo Alto, California, United States
Completed
Ibrutinib in Treating Patients With Refractory or Relapsed Lymphoma After Donor Stem Cell Transplant
NCT02869633
- Conditions
- Blastoid Variant Mantle Cell Lymphoma, Chronic Disease, Disease Attributes, +27 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Stanford Cancer Institute Palo Alto, California, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States
NCT03019640
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +17 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
- Locations
-
- Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
- Hackensack University Medical Center Hackensack, New Jersey, United States
NCT00723099
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, +63 more
- Locations
-
- University of Colorado Hospital Aurora, Colorado, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- LDS Hospital Salt Lake City, Utah, United States
- VA Puget Sound Health Care System Seattle, Washington, United States
NCT01076543
- Conditions
- AIDS-Related Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +27 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States
- Decatur Memorial Hospital Decatur, Illinois, United States
- Ingalls Memorial Hospital Harvey, Illinois, United States
Completed
Pembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma
NCT02950220
- Conditions
- B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma, Blood Protein Disorders, Burkitt Lymphoma, +46 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
Completed
Alisertib and Romidepsin in Treating Patients With Relapsed or Refractory B-Cell or T-Cell Lymphomas
NCT01897012
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +36 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Obinutuzumab With or Without Umbralisib, Lenalidomide, or Combination Chemotherapy in Treating Patients With Relapsed or Refractory Grade I-IIIa Follicular Lymphoma
NCT03269669
- Conditions
- Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma, +12 more
- Locations
-
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
- Anchorage Oncology Centre Anchorage, Alaska, United States
NCT03277729
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +43 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Active, Not Recruiting
Pembrolizumab and Pralatrexate in Treating Patients With Relapsed or Refractory Peripheral T-Cell Lymphomas
NCT03598998
- Conditions
- Anaplastic Large Cell Lymphoma, Enteropathy-Associated T-Cell Lymphoma, Hemic and Lymphatic Diseases, +35 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States